These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 4353527)

  • 1. [Studies on rats with long-term resistance hypertension induced by daily administration of delayed-action preparations of angiotensin].
    Matthias D; Engler E; Baumann H; Wolf I
    Acta Biol Med Ger; 1973; 30(4):505-14. PubMed ID: 4353527
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cardiovascular effects of angiotensin II implantates on the intact unanesthesized rat. A contribution to produce a medium-term experimental hypertension].
    Grieger F; Baumann H; Wolf I
    Acta Biol Med Ger; 1972; 28(1):99-107. PubMed ID: 4340176
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the blood pressure effects of various high doses of angiotensin II in depot form in rats under defined conditions].
    Engler E; Matthias D; Herrmann HJ; Becker CH
    Acta Biol Med Ger; 1976; 35(7):983-94. PubMed ID: 1015170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pressor and subpressor angiotensin II administration. Two experimental models of hypertension.
    Simon G; Abraham G; Cserep G
    Am J Hypertens; 1995 Jun; 8(6):645-50. PubMed ID: 7662251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathomorphological reactions and noradrenalin content of the heart after administration of depot angiotensin in trained and untrained rats].
    Matthias D; Engler E; Will-Shahab L; Herrmann HJ; Becker CH
    Acta Biol Med Ger; 1977; 36(9):1279-84. PubMed ID: 614752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the renal effects of angiotensin II in hypertension.
    Young DB; Lohmeier TE; Hall JE; Declue JE; Bengis RG; Coleman TG; Guyton AC
    Cor Vasa; 1980; 22(1-2):49-58. PubMed ID: 7398346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model].
    Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1203-7. PubMed ID: 8572874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative analysis of effects of prolonged peripheral and intracerebral administration of angiotensin-II to rats].
    Pevtsova EI; Tolpygo SM
    Biull Eksp Biol Med; 1994 Oct; 118(10):352-4. PubMed ID: 7865808
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of synthetic peptide on chronic renal hypertension in the rat.
    Loyke HF
    J Lab Clin Med; 1973 Sep; 82(3):406-11. PubMed ID: 4353878
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance.
    Ran J; Hirano T; Fukui T; Saito K; Kageyama H; Okada K; Adachi M
    Metabolism; 2006 Apr; 55(4):478-88. PubMed ID: 16546478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Blood pressure behavior and pathomorphology in the rat following application of high doses of depot angiotensin].
    Matthias D; Engler E; Herrmann HJ; Becker CH
    Acta Biol Med Ger; 1975; 34(4):625-33. PubMed ID: 1189836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
    Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
    J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidant stress and blood pressure responses to angiotensin II administration in rats fed varying salt diets.
    Pech V; Sikka SC; Sindhu RK; Vaziri ND; Majid DS
    Am J Hypertens; 2006 May; 19(5):534-40. PubMed ID: 16647629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II type 2 receptor gene transfer elicits cardioprotective effects in an angiotensin II infusion rat model of hypertension.
    Falcón BL; Stewart JM; Bourassa E; Katovich MJ; Walter G; Speth RC; Sumners C; Raizada MK
    Physiol Genomics; 2004 Nov; 19(3):255-61. PubMed ID: 15383639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity.
    Ambühl PM; Tissot AC; Fulurija A; Maurer P; Nussberger J; Sabat R; Nief V; Schellekens C; Sladko K; Roubicek K; Pfister T; Rettenbacher M; Volk HD; Wagner F; Müller P; Jennings GT; Bachmann MF
    J Hypertens; 2007 Jan; 25(1):63-72. PubMed ID: 17143175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II-induced hypertension is associated with a selective inhibition of endothelium-derived hyperpolarizing factor-mediated responses in the rat mesenteric artery.
    Dal-Ros S; Bronner C; Schott C; Kane MO; Chataigneau M; Schini-Kerth VB; Chataigneau T
    J Pharmacol Exp Ther; 2009 Feb; 328(2):478-86. PubMed ID: 18984652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct action of an angiotensin II receptor blocker on angiotensin II-induced left atrial conduction delay in spontaneously hypertensive rats.
    Matsuyama N; Tsutsumi T; Kubota N; Nakajima T; Suzuki H; Takeyama Y
    Hypertens Res; 2009 Aug; 32(8):721-6. PubMed ID: 19590505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lyon genetically hypertensive rats: an animal model of "low renin hypertension".
    Sassard J; Lo M; Liu KL
    Acta Pharmacol Sin; 2003 Jan; 24(1):1-6. PubMed ID: 12511223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of angiotensin II antagonism displayed by Ib, a novel nonpeptide angiotensin AT(1) receptor antagonist.
    Wu J; Wang Q; Guo J; Hu Z; Yin Z; Xu J; Wu X
    Eur J Pharmacol; 2008 Jul; 589(1-3):220-4. PubMed ID: 18571160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.